Q-omics provides the consensus-scored TRMT112P5 profile across patient tissues and cancer cell-line models. TRMT112P5 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, TRMT112P5 RNA expression shows 9,360 significant protein co-abundance associations, with the highest sampling consensus in PDAC. Together, these results highlight PAAD, and PDAC as cancer lineages where TRMT112P5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.